Masatomo Otsuka
Nara-shi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 09, 2019
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Journal: Journal of pain and symptom management
Published: May 08, 2019
Factors Associated with Length of Stay at Home in the Final Month of Life among Advanced Cancer Patients: A Retrospective Chart Review.
Journal: Journal of palliative medicine
Published: April 25, 2017
Incidence of carnitine deficiency in patients with cancer pain: A pilot study.
Journal: Molecular and clinical oncology
Published: June 22, 2016
Chemotherapeutic drugs that penetrate the blood-brain barrier affect the development of hyperactive delirium in cancer patients.
Journal: Palliative & supportive care
Published: June 27, 2014
Early palliative intervention for patients with advanced cancer.
Journal: Japanese journal of clinical oncology
Published: June 06, 2013
Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalin.
Journal: Anticancer research
Published: May 18, 2012
Prospective study evaluating the plasma concentrations of twenty-six cytokines and response to morphine treatment in cancer patients.
Journal: Anticancer research
Published: December 27, 2011
Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients.
Journal: Oncology reports
Published: November 01, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026